P09.36 A new therapeutic strategy for newly diagnosed glioblastoma patients: hypofractionated stereotactic radiation therapy (HSRT) delivered in 15 fractions respect to standard fractionation in 30 fractions, with concomitant temozolomide chemotherapy - A phase II study

Introduction: The standard of care, for newly diagnosed glioblastoma multiforme (GBM), consists of surgical resection, followed by radiotherapy with concurrent and adjuvant Temozolomide. Results are still unsatisfactory. Aim of this prospective study was to evaluate outcome of newly diagnosed GBM pa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Navarria, P., Pessina, F., Tomatis, S., Simonelli, M., Santoro, A., Ascolese, A., Clerici, E., Rossi, M., Bello, L., Scorsetti, M.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
POSTER PRESENTATIONS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464241/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.292
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars